medline.ch Onkologie Urologische Tumoren

	Neoadjuvant disitamab vedotin (RC-48) plus a PD-1 inhibitor in muscle-invasive bladder cancer: a multicenter real-world study with stratification by HER2 expression and tertiary lymphoid structures. Front Immunol Rao XP, Zou XC, Liu X, Xu LY, Huang JB, Yuan YY, Chen T, Zeng T. PMID: 42865476 [PubMed - indexed for MEDLINE]
	Clinical Markers of Vulnerability for Bleeding in Men WithÂ Prostate Cancer and Antithrombotic Treatment. Cancer Rep (Hoboken) Björkhem-Bergman L, Hedman C, Szilcz M, Frisk G. PMID: 42865304 [PubMed - indexed for MEDLINE]
	Impact of Prior Holmium Laser Enucleation of the Prostate on Outcomes After Robot-Assisted Radical Prostatectomy. Int J Urol Nishino T, Shimbo M, Oguchi T, Sano M, Narimoto K, Hattori K, Endo F. PMID: 42865148 [PubMed - indexed for MEDLINE]
	Factors Associated With Trifecta and Pentafecta Achievement in Robot-Assisted Laparoscopic Partial Nephrectomy for Highly Complex Renal Tumors. Int J Urol Ishihara H, Nishimura K, Kobari Y, Fukuda H, Yoshida K, Kondo T, Takagi T. PMID: 42865126 [PubMed - indexed for MEDLINE]
	Nanomedicines for prostate cancer therapy: stimuli-responsive design and disease-specific applications. Chem Commun (Camb) Ma Y, Song Z, Yang C, Zhang L. PMID: 42865093 [PubMed - as supplied by publisher]
	Transurethral ultrasound ablation (TULSA) for prostate cancer: a systematic review and meta-analysis. BJU Int Wang E, Wei X, Dua Y, Perera M, Grummet J. PMID: 42864969 [PubMed - as supplied by publisher]
	Association of Travel Time With Definitive Prostate Cancer Treatment: A United States Registry Cohort Study. Cancer Med Dagnino F, Korn S, Daniels D, Qian Z, Stelzl D, Zurl H, Pohl K, Hsieh MC, Hernandez BY, Piccolini A, Lughezzani G, Buffi NM, Lipsitz SR, Reich A, Weissman JS, Cole AP, Trinh QD, Iyer HS. PMID: 42864849 [PubMed - indexed for MEDLINE]
	The role of IFNLR1 in modulating T cell infiltration and cancer progression in renal cell carcinoma. J Transl Med Zheng Y, Wang Y, Zhang M, Zhao M, Zhao X, Cao F, Sun M. PMID: 42864662 [PubMed - indexed for MEDLINE]
	Neutropenia events with androgen receptor pathway inhibitor-containing versus control therapies in prostate cancer patients: a systematic review and meta-analysis. BMC Cancer Zhang J, Zhang A, Tian J, Wang S, Xiao M. PMID: 42864616 [PubMed - indexed for MEDLINE]
	(177)Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Results from the Randomized Phase 2 LUNAR Trial. Eur Urol Kishan AU, Wilhalme H, Felix C, Enke J, Ali FZ, Nabong R, Juarez-Casillas JE, Flores K, Ma TM, Ludwig V, Nakayama M, Ells Z, Dahlbom M, Lauria M, Meyer C, Cao M, Weidhaas JB, Telesca D, McGreevy K, Nickols NG, Parmisano S, Brisbane W, Marks L, Singer AE, Rettig MB, Reiter RE, Valle LF, Allen-Auerbach M, Czernin J, Steinberg ML, Calais J. PMID: 42864228 [PubMed - as supplied by publisher]
	Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials. Crit Rev Oncol Hematol Mollica V, Rosellini M, Giannatempo P, Gupta S, Grande E, Rizzo A, Ricci C, Piazza P, Contieri R, Cattabriga A, Schiavina R, Santoni M, Massari F. PMID: 42863770 [PubMed - as supplied by publisher]
	Ultrasound-controlled therapeutics for bladder cancer: Mechanisms, recent advances, and future perspectives. Colloids Surf B Biointerfaces Loke YL, Lim XY, Beishenaliev A, Goh SJ, Dian Z, Leo BF, Kah JCY, Misran M, Nagai T, Imae T, Chik Z, Chung LY, Teo YY, Ong TA, Hwang DW, Kiew LV. PMID: 42863296 [PubMed - as supplied by publisher]
	Real-World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON-3 Study. Prostate Incorvaia L, Mollica V, Fiala O, Fujita K, Ürün Y, Melichar B, Molina-Cerrillo J, Alonso-Gordoa T, Basso U, Bourlon MT, Seront E, Giorgi U, Fita MJJ, Rescigno P, Taha T, Maluf FC, Poprach A, Summa S, Buchler T, Galli L, Kopecky J, Aurilio G, Kucharz J, Messina C, Polho GB, Scagliarini S, Grillone F, Bastos DA, Formisano L, Spinelli GP, Mosca A, Rizzo A, Bamias A, Monteiro FSM, Soares A, Massari F, Armstrong AJ, Santoni M. PMID: 42862920 [PubMed - as supplied by publisher]
	Impact of a dietary and exercise intervention on health-related quality of life of prostate cancer patients on active surveillance with overweight/obesity: a secondary analysis of a randomized controlled trial. Support Care Cancer Zhu A, Schenk JM, Gulati R, Beatty SJ, VanDoren M, Lin DW, Porter MP, Morrissey C, Dash A, Gore JL, Etzioni R, Plymate SR, Neuhouser ML, Wright JL. PMID: 42862393 [PubMed - indexed for MEDLINE]
	Stage-specific prognostic value of PSA in prostate cancer: a multicentre KAMU-ON study. World J Urol Iwamoto H, Izumi K, Machioka K, Toriumi R, Shima T, Nozaki M, Hori T, Inaba T, Nakagawa R, Kamijima T, Kadomoto S, Makino T, Naito R, Yaegashi H, Shigehara K, Nohara T, Miyagi T, Seto C, Kadono Y, Mizokami A. PMID: 42862366 [PubMed - indexed for MEDLINE]
	PSMA-targeted radioligand therapy in prostate cancer: evidence hierarchy, platform maturity of Â¹â·â·Lu-PSMA-617, and the clinical differentiation challenge for emerging radionuclides. Ann Nucl Med Lin ET. PMID: 42862277 [PubMed - as supplied by publisher]
	Interobserver agreement of non-parallel transmission technology zoomed-diffusion-weighted imaging (DWI) for ordinal biparametric Vesical Imaging-Reporting and Data System (VI-RADS)-based scoring in bladder cancer lesions â‰¥1 cm. Quant Imaging Med Surg Wang D, Zhang Z, Wang Y, Wang Z, Zhang H, Cui C, Zhang Z, Xue N, Zhang M, Liu L. PMID: 42861192 [PubMed]
	Artificial intelligence-based prostate cancer risk stratification via large-scale ultrasound images paired with histopathology. Quant Imaging Med Surg Zhang Q, Lu Q, Liang Y, Chen J, Chen Y, Luo Y. PMID: 42861175 [PubMed]
	CT-guided hybrid cryo-thermal co-ablation versus microwave ablation for stage I renal cell carcinoma: a real-world propensity score-matched comparative study. Quant Imaging Med Surg Li D, Wang Y, Li X. PMID: 42861154 [PubMed]
	Comparative perioperative outcomes of Hugoâ„¢ RAS versus laparoscopic and Da Vinci platforms for partial nephrectomy: a systematic review and meta-analysis. J Robot Surg Lv Z, Zhang R, Wei W, Cai Q, Liu M, Wu J, Liu Q, Li C, Xiong J. PMID: 42860500 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 182127

Seite 1 von 9107

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung